Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 425
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00017498 | Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck | ||
| NCT03590171 | International Study for Treatment of High Risk Childhood Relapsed ALL 2010 | ||
| NCT00433563 | Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung Cancer | ||
| NCT00003976 | E7070 in Treating Patients With Solid Tumors | ||
| NCT00838240 | Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia | ||
| NCT00458913 | Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma | ||
| NCT00039338 | Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer | ||
| NCT00017095 | Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer | ||
| NCT00003772 | Quality-of-Life Assessment in Patients With Ovarian Cancer | ||
| NCT01979393 | IRCI Gynae Sarcomas, High Grade Uterine Sarcoma | ||
| NCT00003014 | Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer | ||
| NCT04065165 | Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome | ||
| NCT00006082 | Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer | ||
| NCT00003642 | Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer | ||
| NCT00014300 | Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme | ||
| NCT01969578 | Androgen Deprivation Therapy in Advanced Salivary Gland Cancer | ||
| NCT00002523 | Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed | ||
| NCT00646659 | Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery | ||
| NCT00005583 | Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer | ||
| NCT06310369 | Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer | ||
| NCT04740372 | Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ | ||
| NCT00227630 | Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma | ||
| NCT00027794 | Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer | ||
| NCT00052312 | Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer | ||
| NCT01957436 | A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer | ||
| NCT02659384 | Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer | ||
| NCT00103168 | Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor | ||
| NCT02295033 | Randomized Boost Versus no Boost Irradiation of Early Breast Cancer | ||
| NCT00039208 | Combination Chemotherapy in Treating Patients With Colorectal Cancer | ||
| NCT00002878 | Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma | ||
| NCT00039364 | Imatinib Mesylate in Treating Patients With Gliomas | ||
| NCT00085228 | Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate | ||
| NCT05065346 | Neoadjuvant DaRT for Locally Advanced Oral Cavity SCC | ||
| NCT00052754 | Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma | ||
| NCT00445952 | Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant | ||
| NCT00020839 | Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain | ||
| NCT01905592 | A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients | ||
| NCT01548677 | Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer | ||
| NCT00006026 | Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract | ||
| NCT00003979 | CHS 828 in Treating Patients With Solid Tumors | ||
| NCT00004151 | Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer | ||
| NCT00003061 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Primary CNS Lymphoma | ||
| NCT01646554 | Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases | ||
| NCT04933942 | Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma | ||
| NCT00003148 | Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia | ||
| NCT03357224 | PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL) | ||
| NCT00949962 | Post-operative or Early Salvage XRT and ADT for High Risk PCa | ||
| NCT06809322 | Vorasidenib Maintenance for IDH Mutant Astrocytoma | ||
| NCT04708548 | Long Term Implications of Rare Brain Tumours' | ||
| NCT02216578 | Ph II CABOGIST in GIST |
